Mallika Alvala (Alvala Mallika)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Future medicinal chemistry

Chemical biology & drug design

ACS infectious diseases

Beilstein journal of organic chemistry

National institute of pharmceutical education and research ,hyderabad

Birla institute of technology and science (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National institute of pharmceutical education and research ,hyderabad Mar 07 2013

India

Faculty :: Medicinal chemistry

Education History

Birla institute of technology and science Aug 13 2010 - Oct 22 2013

India

PHD :: Medicinal chemsitry

Publications

Nerella Sridhar Goud, Ravi Alvala, Arunasree M Kalle, Mallika Alvala
Design and synthesis of novel coumarin-benzimidazole hybrids as human galectin-1 inhibitors. Future medicinal chemistry (2024)
Nerella Sridhar Goud, Ravi Alvala, Arunasree M Kalle, Mallika Alvala
Design and synthesis of novel coumarin-benzimidazole hybrids as human galectin-1 inhibitors. Future medicinal chemistry 16 (9) (2024)
Govinda Raju Vadankula, Vipul V Nilkanth, Arshad Rizvi, Sriram Yandrapally, Anushka Agarwal, Hepshibha Chirra, Rashmita Biswas, Arifuddin Mohammed, Vijay Nema, Mallika Alvala, Shekhar C Mande, Sharmistha Banerjee
Confronting Tuberculosis: A Synthetic Quinoline-Isonicotinic Acid Hydrazide Hybrid Compound as a Potent Lead Molecule Against Mycobacterium tuberculosis . ACS infectious diseases (2024)
Govinda Raju Vadankula, Vipul V Nilkanth, Arshad Rizvi, Sriram Yandrapally, Anushka Agarwal, Hepshibha Chirra, Rashmita Biswas, Arifuddin Mohammed, Vijay Nema, Mallika Alvala, Shekhar C Mande, Sharmistha Banerjee
Confronting Tuberculosis: A Synthetic Quinoline-Isonicotinic Acid Hydrazide Hybrid Compound as a Potent Lead Molecule Against Mycobacterium tuberculosis . ACS infectious diseases 10 (6) (2024)
Nerella Sridhar Goud, Ravi Alvala, Arunasree M Kalle, Mallika Alvala
Design and synthesis of novel coumarin-benzimidazole hybrids as human galectin-1 inhibitors. Future medicinal chemistry 16 (9) (2024)
Nerella Sridhar Goud, Ravi Alvala, Arunasree M Kalle, Mallika Alvala
Design and synthesis of novel coumarin-benzimidazole hybrids as human galectin-1 inhibitors. Future medicinal chemistry 16 (9) (2024)
Nerella Sridhar Goud, Ravi Alvala, Arunasree M Kalle, Mallika Alvala
Design and synthesis of novel coumarin-benzimidazole hybrids as human galectin-1 inhibitors. Future medicinal chemistry 16 (9) (2024)
Sarvesh Mehta, Siddhartha Laghuvarapu, Yashaswi Pathak, Aaftaab Sethi, Mallika Alvala, U Deva Priyakumar
MEMES: Machine learning framework for Enhanced MolEcular Screening. Chemical science 12 (35) (2021)
Aaftaab Sethi, Swetha Sanam, Sharon Munagalasetty, Sivaraman Jayanthi, Mallika Alvala
Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies. RSC advances 10 (50) (2020)
Nerella Sridhar Goud, Venkatesh Pooladanda, Ghouse S Mahammad, Pranay Jakkula, Santhosh Gatreddi, Insaf A Qureshi, Ravi Alvala, Chandraiah Godugu, Mallika Alvala
Synthesis and biological evaluation of morpholines linked coumarin-triazole hybrids as anticancer agents. Chemical biology & drug design 94 (5) (2020)
Kesari Lakshmi Manasa, Yellaiah Tangella, Namballa Hari Krishna, Mallika Alvala
A metal-free approach for the synthesis of amides/esters with pyridinium salts of phenacyl bromides via oxidative C-C bond cleavage. Beilstein journal of organic chemistry 15 (2019)
Amaroju Suresh, Singireddi Srinivasarao, Napiórkowska Agnieszka, Augustynowicz-Kopeć Ewa, Mallika Alvala, Christian Lherbet, Kondapalli Venkata Gowri Chandra Sekhar
Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors. Chemical biology & drug design 91 (6) (2018)
Pratima Khadkikar, N Sridhar Goud, Arifuddin Mohammed, Gayathri Ramamoorthy, Ragamanvitha Ananthathatmula, Mukesh Doble, Arshad Rizvi, Sharmista Banerjee, Alvala Ravi, Mallika Alvala
An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors. Chemical biology & drug design 92 (6) (2018)

Mallika Alvala.css-eqlu8i{font-size:small;padding-left:4px;} (Alvala Mallika)

Publication Activity (10 Years)

Top Topics

Top Venues

Mallika Alvala (Alvala Mallika)